Defunct Company
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
108
NCT02654041
Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2016
Completion: Jun 30, 2017
NCT04473053
DEFINE - Evaluating Therapies for COVID-19
Phase: Phase 1/2
Role: Collaborator
Start: Jul 3, 2020
Completion: Apr 30, 2025
NCT04455815
A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)
Start: Sep 23, 2020
Completion: Mar 3, 2022